Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Quinnova brings in $17.4mm through its Series B round

Executive Summary

Quinnova Pharmaceuticals (topical dermatology therapeutics) has raised $17.4mm through its Series B venture round. Safeguard Scientifics led the financing with its $5mm investment (and contributed a board member), and was joined by existing shareholders Thomas, McNerney & Partners and HIG BioVentures.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
      • Transdermal
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies